SNHG10:一种新的长非编码RNA,在人类癌症中具有多方面的作用
Haodong He1,2, Jingjie Yang1,2, Yan Zhou1,2
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
Current pharmaceutical design
|March 6, 2025
概括
小核RNA宿主基因10 (SNHG10) 是一种长非编码RNA (lncRNA),与癌症进展有关. 这篇评论探讨了SNHG10的SNHG10.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 长非编码RNAs (lncRNAs) 调节基因表达和癌症生物学.
- 小核RNA宿主基因10 (SNHG10) 是一种涉及各种癌症的新型 lncRNA.
- 异常的SNHG10表达与瘤进展相关,包括增殖,迁移,入侵,EMT和化学抵抗.
研究的目的:
- 审查SNHG10在癌症中的生物功能和分子机制.
- 探索SNHG10在瘤发生中的作用,包括其参与ceRNA网络,表观遗传调节,免疫反应和代谢重编程.
- 突出SNHG10作为诊断生物标志物和精密瘤学的治疗点的潜力.
主要方法:
- 关于SNHG10在各种癌症中的最新研究的文献综述.
- 分析SNHG10的分子机制,包括它与上游监管器和下游目标的相互作用.
- 研究SNHG10在与瘤生物学相关的核和细胞质过程中的参与.
主要成果:
- 在多种癌症类型中,SNHG10表现出异常表达.
- SNHG10影响关键的瘤发生过程,如增殖,迁移,入侵,EMT和化疗耐药性.
- SNHG10通过多种机制发挥作用,包括ceRNA活性,表观遗传调节,免疫反应调节和代谢重编程.
结论:
- 在瘤生物学中,SNHG10是一个重要的参与者,具有多样化的作用.
- 它的特定表达模式表明它有可能成为诊断生物标志物.
- 准SNHG10可能为各种癌症提供新的治疗策略,推进精确瘤学.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Types of RNA
5.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.5K
RNA Splicing
55.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.9K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K


